• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

47.3700 USD 1.1100 2.40%

As of 20:04:06 ET on 10/21/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 46.8300 High - Low: 47.3700 - 46.5500 Primary Exchange: NYSE Arca
Volume: 75,168 52-Week Range: 33.9600 - 48.1200 Beta vs DZOTR: 0.9986

ETF Chart for PBE

No chart data available.
  • PBE:US 47.3700
  • 1D
  • 1M
  • 1Y
46.2600
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-10-21) 47.3396
Assets (M) (on 2014-10-21) 404.7540
Shares out (M) 8.55
Market Cap (M) 405.01
% Premium 0.06
Average 52-Week % Premium 0.0142
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.58%

Performance for PBE

1-Month +2.62% 1-Year +38.64%
3-Month +11.90% 3-Year +33.78%
Year To Date +28.65% 5-Year +23.80%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 10/21/2014
Name Position Value % of Total
Sigma-Aldrich Corp 193,912 26,294,467 6.495%
Regeneron Pharmaceuticals Inc 57,534 21,921,029 5.414%
Amgen Inc 144,690 20,848,382 5.149%
Alexion Pharmaceuticals Inc 119,126 20,784,509 5.134%
Illumina Inc 112,438 20,188,243 4.986%
Gilead Sciences Inc 187,459 19,996,252 4.939%
Biogen Idec Inc 58,789 19,210,482 4.745%
Pharmacyclics Inc 162,126 18,897,407 4.668%
Repligen Corp 577,129 13,112,371 3.239%
Insys Therapeutics Inc 311,441 12,087,025 2.985%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil